Industrial Goods » Precision Products | Danaher Corp.

Danaher Corp. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
19,118
19,914
14,434
16,882
18,330
19,893
Cost of Goods Sold (COGS) incl. D&A
9,160
9,425
6,520
7,499
8,099
8,769
Gross Income
9,958
10,488
7,914
9,383
10,231
11,124
SG&A Expense
6,590
6,886
5,496
6,396
7,050
7,650
EBIT
3,368
3,602
-
2,987
3,180
3,474
Unusual Expense
93
171
256
415
159
70
Non Operating Income/Expense
431
157
12
223
73
37
Interest Expense
146
123
140
184
163
157
Pretax Income
3,566
3,482
2,039
2,611
2,939
3,293
Income Tax
871
883
293
458
469
642
Consolidated Net Income
2,695
2,598
1,747
2,153
2,470
2,651
Net Income
2,695
2,598
1,747
2,153
2,470
2,651
Net Income After Extraordinaries
2,695
2,598
136
1,753
2,448
2,651
Net Income Available to Common
2,695
2,598
2,597
2,554
2,492
2,651
EPS (Basic)
3.80
3.63
4.74
3.65
3.53
3.74
Basic Shares Outstanding
696
702
698
691
696
701
EPS (Diluted)
3.80
3.63
4.74
3.65
3.53
3.74
Diluted Shares Outstanding
711
716
709
700
706
710
EBITDA
4,263
4,541
3,299
4,115
4,419
4,782
Non-Operating Interest Income
-
6
17
5
8
9

About Danaher

View Profile
Address
2200 Pennsylvania Avenue NW
Washington District of Columbia 20037
United States
Employees -
Website http://www.danaher.com
Updated 07/08/2019
Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment. It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research and clinical tools that scientists use to study cells and cell components in order to understand the causes of diseases; identify new therapies; and test new drugs and vaccines.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.